论文部分内容阅读
目的：探讨黄芪对肝硬化患者血清前白蛋白的影响。方法：观察两组患者治疗前后血清前白蛋白升高程度及临床症状、体征改善情况。结果：两组治疗后血清前白蛋白均升高，尤以治疗组较对照组升高更显著（Ｐ＜０００１），且治疗组治疗前后比较白蛋白（ＡＬＢ）升高，谷丙转氨酶（ＡＬＴ）下降均较明显（Ｐ＝００５，Ｐ＜００５）；同时临床纳差、腹胀、腹水改善情况治疗组与对照组比较差异有显著性意义（Ｐ＜００５）。结论：黄芪能明显改善肝硬化患者肝脏蛋白质合成功能及相应的临床症状。
Objective: To investigate the effect of astragalus on serum prealbumin in cirrhotic patients. Methods: The levels of serum prealbumin, clinical symptoms and signs in two groups were observed before and after treatment. Results: Serum prealbumin levels increased after treatment in both groups, especially in the treatment group than in the control group (P <0001). The levels of albumin in the treatment group before and after treatment were elevated, (ALT) decreased significantly (P = 005, P <005). Meanwhile, there was significant difference between the treatment group and the control group (P <005). Conclusion: Astragalus can significantly improve liver cirrhosis patients with protein synthesis and the corresponding clinical symptoms.